Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss

Dixon, John B., Bhathal, Prithi S., Hughes, Norman R., O'Brien, Paul E.·2004·Hepatology
DOI 10.1002/hep.20251

Cited by (724)

Items 201–300 of 724

  1. Gastrointestinal Hormones, Intestinal Microbiota and Metabolic Homeostasis in Obese Patients: Effect of Bariatric Surgery.
    Alessandro Federico, Marcello Dallio, Salvatore Tolone, Antonietta Gerarda Gravina, Vania Patrone, Marco Romano, Concetta Tuccillo, Anna Licia Mozzillo, Vincenzo Amoroso, Gabriella Misso et al. · 2016 · PubMed
  2. A Review of Non-Alcoholic Fatty Liver Disease in HIV-Infected Patients: The Next Big Thing?
    Berend J. van Welzen, Tania Mudrikova, Ayman El Idrissi, Andy I. M. Hoepelman, Joop E. Arends · 2019 · Infectious Diseases and Therapy
  3. Effects of sodium–glucose cotransporter 2 inhibitors on non‐alcoholic fatty liver disease in patients with type 2 diabetes: A meta‐analysis of randomized controlled trials
    Baodi Xing, Yuhang Zhao, Bingzi Dong, Yue Zhou, Wenshan Lv, Wenjuan Zhao · 2020 · Journal of Diabetes Investigation
  4. Pathogenesis and therapeutic approaches for non-alcoholic fatty liver disease
    Hyejin Yoon · 2014 · World Journal of Hepatology
  5. Effect of a dietary-induced weight loss on liver enzymes in obese subjects
    Gasteyger, Christoph, Larsen, Thomas Meinert, Vercruysse, Frank, Astrup, Arne · 2008 · The American Journal of Clinical Nutrition
  6. Fatty acid and non-alcoholic fatty liver disease: Meta-analyses of case-control and randomized controlled trials
    Xiaofei Guo, Bo Yang, Jun Tang, Duo Li · 2017 · Clinical Nutrition
  7. Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review.
    D Shyangdan, Christine Clar, Nazim Ghouri, R Henderson, Tul Maya Gurung, David Preiss, Naveed A. Sattar, Abigail Fraser, Norman R Waugh · 2011 · Health Technology Assessment
  8. Histologic improvement of NAFLD in patients with obesity after bariatric surgery based on standardized NAS (NAFLD activity score)
    Witigo V Schönfels, Jan Henrik Beckmann, Markus Ahrens, Alexander Hendricks, Christoph Röcken, Silke Szymczak, Jochen Hampe, Clemens Schafmayer · 2018 · Surgery for Obesity and Related Diseases
  9. Influence of Visceral Obesity and Liver Fat on Vascular Structure and Function in Obese Subjects
    Wolfgang Sturm, A. Sandhofer, Julia Engl, Markus Wolfgang Laimer, Clemens Molnar, Susanne Kaser, Helmut G Weiss, Herbert Tilg, Christoph F. Ebenbichler, Josef R. Patsch · 2009 · Obesity
  10. How should we manage patients with non‐alcoholic fatty liver disease in 2007?
    Henry Lik‐Yuen Chan, H Janaka de Silva, Nancy W.Y. Leung, Seng Gee Lim, Geoffrey C. Farrell, the Asia–Pacific Working Party on NAFLD · 2007 · Journal of Gastroenterology and Hepatology
  11. Lifestyle intervention for non-alcoholic fatty liver disease: prospective cohort study of its efficacy and factors related to improvement
    Bart G.P. Koot, Olga H. van der Baan‐Slootweg, C L J Tamminga-Smeulders, Tammo H. Pels Rijcken, Joke C. Korevaar, Wim M. C. van Aalderen, Peter L. M. Jansen, Marc Alexander Benninga · 2011 · Archives of Disease in Childhood
  12. Anti-inflammatory microRNA-146a protects mice from diet-induced metabolic disease
    Marah C. Runtsch, Morgan C. Nelson, Soh-Hyun Lee, Warren P. Voth, Margaret Alexander, Ruozhen Hu, Jared A. Wallace, Charisse Petersen, Vanja Panic, Claudio J. Villanueva et al. · 2019 · PLoS Genetics
  13. Bariatric Surgery-Induced Weight Loss Reduces Hepatic Lipid Peroxidation Levels and Affects Hepatic Cytochrome P-450 Protein Content
    Lauren Nicole Bell, Constance J. Temm, Rashmil Saxena, Raj Vuppalanchi, Philip R. Schauer, Mordechai Rabinovitz, Alyssa M. Krasinskas, Naga Chalasani, Samer Gamil Mattar · 2010 · Annals of Surgery
  14. Prevalence and Predictive Factors of Non-Alcoholic Steatohepatitis (NASH) in Morbidly Obese Patients Undergoing Bariatric Surgery
    Florence Harnois, Simon Msika, Jean‐Marc Sabaté, Charlotte Mechler, Pauline Jouet, Jeanine Barge, Benoît Coffin · 2006 · Obesity Surgery
  15. Bariatric Surgery Can Correct Iron Depletion in Morbidly Obese Women: A Link with Chronic Inflammation
    Rodolphe Anty, Monsef Dahman, Antonio Iannelli, Philippe Gual, Aline Staccini-Myx, Imed Ben Amor, Nathalie Luciani, Marie‐Christine Saint‐Paul, Pierre–Michel Huet, Jean‐Louis Sadoul et al. · 2008 · Obesity Surgery
  16. Liver fatty acid composition in mice with or without nonalcoholic fatty liver disease
    Xin Wang, Yuzhen Cao, Yunwei Fu, Guifang Guo, Xiuying Zhang · 2011 · Lipids in Health and Disease
  17. Urinary metabolomics analysis identifies key biomarkers of different stages of nonalcoholic fatty liver disease
    Shu Dong, Zong-Ying Zhan, Hongyan Cao, Chao Wu, Yanqin Bian, Jianyuan Li, Genhong Cheng, Ping Liu, Mingyu Sun · 2017 · World Journal of Gastroenterology
  18. Histological progression of non‐alcoholic fatty liver disease: a critical reassessment based on liver sampling variability
    Vlad Ratziu, Elisabetta Bugianesi, John B. Dixon, E Fassio, Mattias Ekstedt, Frédéric Charlotte, Stergios Kechagias, Thierry Poynard, Rolf Olsson · 2007 · Alimentary Pharmacology & Therapeutics
  19. Values and limitations of serum aminotransferases in clinical trials of nonalcoholic steatohepatitis
    Ayako Suzuki, James F. Lymp, Jennifer L. St. Sauver, Paul Angulo, Keith D. Lindor · 2006 · Liver International
  20. Surgically induced weight loss by gastric bypass improves non alcoholic fatty liver disease in morbid obese patients
    Vargas, Víctor, Allende, Helena, Lecube, Albert, Salcedo, Maria Teresa, Baena-Fustegueras, Juan A, Fort, José M, Rivero, Joaquín, Ferrer, Roser, Catalán, Roberto, Pardina, Eva et al. · 2012 · World Journal of Hepatology
  21. Ursodeoxycholic acid with vitamin E in patients with nonalcoholic steatohepatitis: Long-term results
    Florence Juget Pietu, Olivier Guillaud, Thomas Walter, Mélanie Vallin, Valérie Hervieu, Jean‐Yves Scoazec, Jérôme Dumortier · 2011 · Clinics and Research in Hepatology and Gastroenterology
  22. Nonalcoholic Fatty Liver Disease
    Angelo H. Paredes, Dawn McDowell Torres, Stephen A. Harrison · 2012 · Clinics in Liver Disease
  23. Cost-effectiveness analysis: risk stratification of nonalcoholic fatty liver disease (NAFLD) by the primary care physician using the NAFLD fibrosis score
    Tapper, Elliot B., Hunink, M. G. Myriam, Afdhal, Nezam H., Lai, Michelle, Sengupta, Neil · 2016 · PLoS ONE
  24. Current Treatment Options for Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis
    Melanie D. Beaton · 2012 · Canadian Journal of Gastroenterology
  25. An overview of nonalcoholic steatohepatitis: past, present and future directions.
    Alina Pascale, Raluca Pais, Vlad Ratziu · 2010 · PubMed
  26. Protective effects of the Alisma orientalis extract on the experimental nonalcoholic fatty liver disease
    Xuezhi Hong, Huiqing Tang, Limao Wu, LI Lian-da · 2005 · Journal of Pharmacy and Pharmacology
  27. Herbal medicines for fatty liver diseases
    Zhao Lan Liu, Liang Zhen Xie, Jiang Zhu, George Qian Li, Suzanne Jane Grant, Jian Ping Liu · 2013 · Cochrane Database of Systematic Reviews
  28. Management of nonalcoholic fatty liver disease: An evidence-based clinical practice review
    Juan Pablo Arab · 2014 · World Journal of Gastroenterology
  29. Automated liver stiffness measurements with magnetic resonance elastography
    Bogdan Dzyubak, Kevin J. Glaser, Meng Yin, Jayant A. Talwalkar, Jun Chen, Armando Manduca, Richard L. Ehman · 2012 · Journal of Magnetic Resonance Imaging
  30. Pentoxifylline and melatonin in combination with pioglitazone ameliorate experimental non-alcoholic fatty liver disease
    Sawsan A. Zaitone, Neven Hassan, Naglaa F. El-Orabi, El‐Sayed El‐Awady · 2011 · European Journal of Pharmacology
  31. Review article: drug therapy for non‐alcoholic fatty liver disease
    Kevin M. Comar, Richard K. Sterling · 2005 · Alimentary Pharmacology & Therapeutics
  32. Automated liver elasticity calculation for MR elastography
    Bogdan Dzyubak, Sudhakar Kundapur Venkatesh, Armando Manduca, Kevin J. Glaser, Richard L. Ehman · 2015 · Journal of Magnetic Resonance Imaging
  33. Treatment strategies in nonalcoholic fatty liver disease
    Herbert Tilg, Arthur Kaser · 2005 · Nature Clinical Practice Gastroenterology &#38 Hepatology
  34. Long-term Outcome of Bariatric Surgery: An Interim Analysis
    Robert F. Kushner, Courtney A. Noble · 2006 · Mayo Clinic Proceedings
  35. Short‐term Outcome in the First 10 Morbidly Obese Adolescent Patients in the FDA‐approved Trial for Laparoscopic Adjustable Gastric Banding
    Ai‐Xuan Holterman, Allen F. Browne, Barney E Dillard, Lisa Tussing, Verónica Gorodner, Christiane Stahl, Nancy Tkacz Browne, Sue Labott, James J. Herdegen, Grace Guzman et al. · 2007 · Journal of Pediatric Gastroenterology and Nutrition
  36. Nonalcoholic Fatty Liver Disease: A Practical Approach to Evaluation and Management
    Nila Rafiq, Zobair M. Younossi · 2009 · Clinics in Liver Disease
  37. Nonalcoholic Fatty Liver Disease and the Metabolic Syndrome
    Robert S. Rahimi, Carmen E. Landaverde · 2013 · Nutrition in Clinical Practice
  38. Molecular interplays in hepatic stellate cells: apoptosis, senescence, and phenotype reversion as cellular connections that modulate liver fibrosis
    Brenda de Oliveira da Silva, Letícia Ferreira Ramos, Karen C. M. Moraes · 2017 · Cell Biology International
  39. Non-alcoholic fatty liver disease
    Jane D Collier · 2006 · Medicine
  40. Controversies in the management of pediatric liver disease: Hepatitis B, C and NAFLD: Summary of a single topic conference
    Benjamin L. Shneider, Regino P. González‐Peralta, Eve A. Roberts · 2006 · Hepatology
  41. Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD)—A Condition Associated with Heightened Sympathetic Activation
    Revathy Carnagarin, Kearney Tan, Leon Anton Adams, Vance Bruce Matthews, Márcio Galindo Kiuchi, Leslie Marisol Lugo‐Gavidia, Gavin William Lambert, Élisabeth Lambert, Lakshini Yasaswi Herat, Markus Peter Schlaich · 2021 · International Journal of Molecular Sciences
  42. Fatty Liver Disease: Predictors of Nonalcoholic Steatohepatitis and Gallbladder Disease in Morbid Obesity
    Phui‐Ly Liew, Wei‐Jei Lee, Weu Wang, Yi-Chih Lee, Wei‐Yu Chen, Chia-Lang Fang, Ming‐Te Huang · 2008 · Obesity Surgery
  43. Non-alcoholic fatty liver disease: is bariatric surgery the answer?
    A. Pillai, M. Rinella · 2009 · Clinical Liver Disease
  44. Role of physical activity in nonalcoholic fatty liver disease in terms of visceral obesity and insulin resistance
    Min‐Sun Kwak, Donghee Kim, Goh Eun Chung, Won Kyum Kim, Yoon Jun Kim, Jung‐Hwan Yoon · 2014 · Liver International
  45. Non-alcoholic fatty liver disease
    Einar Stefan Bjornsson, Paul Angulo · 2007 · Scandinavian Journal of Gastroenterology
  46. Green cardamom supplementation improves serum irisin, glucose indices, and lipid profiles in overweight or obese non-alcoholic fatty liver disease patients: a double-blind randomized placebo-controlled clinical trial
    Milad Daneshi‐Maskooni, Seyed Ali Keshavarz, Mostafa Qorbani, Siavash Mansouri, Seyed Moayed Alavian, Mahtab Badri-Fariman, Seyed Ali Jazayeri-Tehrani, Gity Sotoudeh · 2019 · BMC Complementary and Alternative Medicine
  47. Bile acids for non-alcoholic fatty liver disease and/or steatohepatitis
    Rocco Orlando, Lorenzo Azzalini, Serena Orando, Flavio Lirussi · 2007 · Cochrane Database of Systematic Reviews · Retracted
  48. Non‐alcoholic fatty liver disease
    Ana C. Tuyama, Charissa Chang · 2012 · Journal of Diabetes
  49. Bariatric Surgery and Liver Disease: General Considerations and Role of the Gut–Liver Axis
    Maria Cerreto, Francesco Santopaolo, Antonio Gasbarrini, Maurizio Pompili, Francesca Romana Ponziani · 2021 · Nutrients
  50. Green cardamom increases Sirtuin-1 and reduces inflammation in overweight or obese patients with non-alcoholic fatty liver disease: a double-blind randomized placebo-controlled clinical trial
    Milad Daneshi‐Maskooni, Seyed Ali Keshavarz, Mostafa Qorbani, Siavash Mansouri, Seyed Moayed Alavian, Mahtab Badri-Fariman, Seyed Ali Jazayeri-Tehrani, Gity Sotoudeh · 2018 · Nutrition & Metabolism
  51. Insulin-Like Growth Factor-1 Deficiency and Cirrhosis Establishment
    de la Garza, Rocio G., Morales-Garza, Luis Alonso, Martin-Estal, Irene, Castilla-Cortazar, Inma · 2017 · Journal of Clinical Medicine Research
  52. Nonalcoholic steatohepatitis
    Brian P. Mulhall, Zobair M. Younossi · 2004 · Current Treatment Options in Gastroenterology
  53. Herbal medicines for fatty liver diseases
    Zhaolan Liu, Jiang Zhu, Yanan Wu, Xi'e Zhuang, Jianping Liu · 2011 · Cochrane Database of Systematic Reviews
  54. Liver Fibrosis: Possible Involvement of EMT
    Tadashi Ikegami, Yining Zhang, Yasushi Matsuzaki · 2007 · Cells Tissues Organs
  55. The liver and the waistline: Fifty years of growth
    Geoffrey C. Farrell · 2009 · Journal of Gastroenterology and Hepatology
  56. Heterogeneity of fibrosis patterns in non‐alcoholic fatty liver disease supports the presence of multiple fibrogenic pathways
    Richard Skoien, Michelle M. Richardson, Julie R. Jonsson, Elizabeth Ellen Powell, Elizabeth M. Brunt, Brent A. Neuschwander‐Tetri, Prithi S. Bhathal, John B. Dixon, Paul E. O’Brien, Herbert Tilg et al. · 2013 · Liver International
  57. Diagnosis and treatment of pediatric nonalcoholic steatohepatitis and the implications for bariatric surgery
    Perrie E. Pardee, Joel E. Lavine, Jeffrey B. Schwimmer · 2009 · Seminars in Pediatric Surgery
  58. Nonalcoholic fatty liver disease and bariatric surgery: a comprehensive review
    Everton Cazzo, José Carlos Pareja, Élinton Adami Chaim · 2017 · Sao Paulo Medical Journal
  59. Antidiabetic Medications for Type 2 Diabetics with Nonalcoholic Fatty Liver Disease: Evidence From a Network Meta-Analysis of Randomized Controlled Trials
    Cheng Han Ng, Snow Yunni Lin, Yip Han Chin, Ming Hui Lee, Nicholas L. X. Syn, Xin Lei Goh, Jin Hean Koh, Jingxuan Quek, Darren Jun Hao Tan, Shao Feng Mok et al. · 2021 · Endocrine Practice
  60. Review article: non‐alcoholic fatty liver disease in morbidly obese patients and the effect of bariatric surgery
    Rogier J.J. de Ridder, Erik J. Schoon, Johannes Franciscus Smulders, Gerbrand C. M. van Hout, Reinhold W. Stockbrügger, Ger H. Koek · 2007 · Alimentary Pharmacology & Therapeutics
  61. Fibrosis and Cirrhosis Reversibility: Clinical Features and Implications
    Massimo Pinzani, Francesco Vizzutti · 2008 · Clinics in Liver Disease
  62. Liver fibrosis quantification
    Sudhakar Kundapur Venkatesh, Michael S Torbenson · 2022 · Abdominal Radiology
  63. Prevalence of nonalcoholic steatohepatitis in Japanese patients with morbid obesity undergoing bariatric surgery
    Yosuke Seki, Satoru Kakizaki, Norio Horiguchi, Hiroaki Hashizume, Hiroki Tojima, Yuichi Yamazaki, Ken Sato, Motoyasu Kusano, Masanobu Yamada, Kazunori Kasama · 2015 · Journal of Gastroenterology
  64. Pure total flavonoids from citrus attenuate non-alcoholic steatohepatitis via regulating the gut microbiota and bile acid metabolism in mice
    Beihui He, Jianping Jiang, Zheng Shi, Liyan Wu, Junbin Yan, Zheng Chen, Minmin Luo, Dawei Cui, Sumei Xu, Maoxiang Yan et al. · 2021 · Biomedicine & Pharmacotherapy
  65. Novel treatment modalities for nonalcoholic steatohepatitis
    Sanjaya Kumar Satapathy, Arun Jayant Sanyal · 2010 · Trends in Endocrinology and Metabolism
  66. Current and Emerging Therapies in Nonalcoholic Fatty Liver Disease
    M. Kashi, D. Torres, Stephen D. Harrison · 2008 · Seminars in liver disease (Print)
  67. Rapid Reversal of Liver Steatosis With Life Style Modification in Highly Motivated Liver Donors
    Narendra Singh Choudhary, Neeraj Saraf, Sanjiv Saigal, Dheeraj Gautam, Lipika Lipi, Amit Nath Rastogi, Sanjay K. Goja, Palat Balachandran Menon, Prashant Bhangui, Sumana K. Ramchandra et al. · 2015 · Journal of Clinical and Experimental Hepatology
  68. Preoperative Assessment and Perioperative Care of Patients Undergoing Bariatric Surgery
    Rajesh Kuruba, Lisa Saff Koche, Michel M. Murr · 2007 · Medical Clinics of North America
  69. Prevalence and Predictors of Non-Alcoholic Fatty Liver Disease in Morbidly Obese South Indian Patients Undergoing Bariatric Surgery
    Palanivelu Praveenraj, Rachel M. Gomes, Saravana S Kumar, Purushothaman Karthikeyan, Shankar Annapoorni, Ramakrishnan Parthasarathi, Palanisamy Senthilnathan, Subbiah Rajapandian, Chinnusamy Palanivelu · 2015 · Obesity Surgery
  70. Probiotics and synbiotics may improve liver aminotransferases levels in non-alcoholic fatty liver disease patients
    Caroline Buss, Cristiane Valle Tovo, S.A.S. Miozzo, Ângelo Alves de Mattos · 2014 · Annals of Hepatology
  71. Nutritional aspects in patients with non-alcoholic steatohepatitis (NASH).
    Esmeralda Capristo, Luca Miele, A. Forgione, Vittoria Vero, Sara Farnetti, Geltrude Mingrone, A V Greco, Giovanni Gasbarrini, Antonio Grieco · 2005 · PubMed
  72. Evidence-Based Exercise Recommendations to Reduce Hepatic Fat Content in Youth- a Systematic Review and Meta-Analysis
    María Medrano, Cristina Cadenas‐Sánchez, Celia Álvarez‐Bueno, Iván Cavero‐Redondo, Jonatan R. Ruiz, Francisco B. Ortega, Idoia Labayen · 2018 · Progress in Cardiovascular Diseases
  73. Histological Changes in the Liver of Morbidly Obese Patients: Correlation with Metabolic Parameters
    Anna Maria Wolf, Bernd Busch, Hans Werner Kuhlmann, Ulrike Beisiegel† · 2005 · Obesity Surgery
  74. The effects of bariatric surgeries on nonalcoholic fatty liver disease
    Aldoheyan, Tamadar, Hassanain, Mazen, Al-Mulhim, Amnah, Al-Sabhan, Atheer, Al-Amro, Shaden, Bamehriz, Fahad, Al-Khalidi, Hisham · 2017 · Surgical Endoscopy
  75. Bariatric surgery for curing NASH in the morbidly obese?
    Guillaume Lassailly, Robert J. Caiazzo, François N. Pattou, Philippe Mathurin · 2013 · Journal of Hepatology
  76. Effects of weight loss on liver and erythrocyte polyunsaturated fatty acid pattern and oxidative stress status in obese patients with non-alcoholic fatty liver disease
    ALEJANDRA ELIZONDO, Julia Araya A., Ramón Rodrigo, Cinzia Signorini, Cristiana Sgherri, Mario Comporti, Jaime Poníachik, Luis Alberto Videla · 2008 · Biological Research
  77. Present and future therapeutic strategies in non-alcoholic fatty liver disease
    Giuseppe Calamita, Piero Portincasa · 2007 · Expert Opinion on Therapeutic Targets
  78. Current and future treatment options in non-alcoholic steatohepatitis (NASH)
    Nikolaos Lazaridis, Emmanuel A. Tsochatzis · 2017 · Expert Review of Gastroenterology & Hepatology
  79. Efficacy of tumour necrosis factor antagonists in stricturing Crohn’s disease: A tertiary center real-life experience
    Mariangela Allocca, Cristiana Bonifacio, Gionata Fiorino, Antonino Spinelli, Federica Furfaro, Luca Balzarini, Stefanos Bonovas, Silvio Danese · 2017 · Digestive and Liver Disease
  80. Kallistatin, a new and reliable biomarker for the diagnosis of liver cirrhosis
    Zhiyun Cheng, Yinghui Lv, Su-Qiu Pang, Ruyu Bai, Mingxi Wang, Shuyu Lin, Tianwen Xu, Duncan R.C. Spalding, Nagy Adley Habib, Ruian Xu · 2015 · Acta Pharmaceutica Sinica B
  81. Treatment of Nonalcoholic Fatty Liver Disease: The Role of Medical, Surgical, and Endoscopic Weight Loss
    Violeta Popov, Joseph K. Lim · 2015 · Journal of Clinical and Translational Hepatology
  82. Association Between Index of Nutritional Quality and Nonalcoholic Fatty Liver Disease: The Role of Vitamin D and B Group
    Farhad Vahid, Azita Hekmatdoost, Sousan Mirmajidi, Saeid Doaei, Diyako Rahmani, Zeinab Faghfoori · 2019 · The American Journal of the Medical Sciences
  83. Impact of sleeve gastrectomy and Roux-en-Y gastric bypass on biopsy-proven non-alcoholic fatty liver disease
    Cherla, Deepa V., Rodriguez, Noe A., Vangoitsenhoven, Roman, Singh, Tavankit, Mehta, Neal, McCullough, Arthur J., Brethauer, Stacy A., Schauer, Philip R., Aminian, Ali · 2020 · Surgical Endoscopy
  84. Research on the protection effect of pioglitazone for non-alcoholic fatty liver disease (NAFLD) in rats
    Ping Xu, Xingguo Zhang, Youming Li, Chaohui Yu, Lei Xu, Gen-Yun Xu · 2006 · Journal of Zhejiang University SCIENCE B
  85. Effect of Weight Loss on Nonalcoholic Fatty Liver Disease
    Anish A Patel, Dawn McDowell Torres, Stephen A. Harrison · 2009 · Journal of Clinical Gastroenterology
  86. Treatment regimens for non-alcoholic fatty liver disease
    Brian P Lam, Zobair M. Younossi · 2009 · Annals of Hepatology
  87. Plasma cathepsin D correlates with histological classifications of fatty liver disease in adults and responds to intervention
    Sofie M. A. Walenbergh, Tom Houben, Sander S. Rensen, Veerle Bieghs, Tim Hendrikx, Patrick J. van Gorp, Yvonne Oligschlaeger, Mike L. J. Jeurissen, Marion J. Gijbels, Wim A. Buurman et al. · 2016 · Scientific Reports
  88. Consenso mexicano de la enfermedad por hígado graso no alcohólico
    Raúl Bernal-Reyes, Graciela Castro‐Narro, René Malé-Velázquez, Ramón Carmona-Sánchez, M.S. González-Huezo, Ignacio García-Juárez, Norberto Carlos Chávez-Tapia, C. Aguilar-Salinas, I. Aiza-Haddad, M.A. Ballesteros-Amozurrutia et al. · 2019 · Revista de Gastroenterología de México
  89. The clinical effects of purslane ( Portulaca oleracea ) seeds on metabolic profiles in patients with nonalcoholic fatty liver disease: A randomized controlled clinical trial
    Alireza Gheflati, Elham Adelnia Najafabadi, Azadeh Nadjarzadeh · 2019 · Phytotherapy Research
  90. Long-term therapy of chronic hepatitis B reverses cirrhosis
    Anna Suk-Fong Lok · 2013 · Nature Reviews Gastroenterology & Hepatology
  91. Treatment of Non-Alcoholic Fatty Liver Disease
    Jessica Katharine Dyson, Chris Day · 2014 · Digestive Diseases
  92. Amelioration of intestinal barrier dysfunction by berberine in the treatment of nonalcoholic fatty liver disease in rats
    Yiyuan Li, Jimin Zheng, Yiting Hu, Hongtao Hou, Shurong Hao, Na Liu, Yuzhen Wang · 2017 · Pharmacognosy Magazine
  93. Metabolic syndrome after liver transplantation: Preventable illness or common consequence?
    Eric R. Kallwitz · 2012 · World Journal of Gastroenterology
  94. Single-cell transcriptome and cell type-specific molecular pathways of human non-alcoholic steatohepatitis
    Fred, Rikard G., Steen Pedersen, Julie, Thompson, Jonatan J., Lee, Julie, Timshel, Pascal N., Stender, Stefan, Opseth Rygg, Marte, Gluud, Lise Lotte, Bjerregaard Kristiansen, Viggo, Bendtsen, Flemming et al. · 2022 · Scientific Reports
  95. Non-alcoholic fatty liver disease and the metabolic syndrome: Effects of weight loss and a review of popular diets. Are low carbohydrate diets the answer?
    Harjot Gill, George Y. Wu · 2006 · World Journal of Gastroenterology
  96. Prevalence of Non-alcoholic Fatty Liver Disease and Steatohepatitis Risk Factors in Patients Undergoing Bariatric Surgery
    Shinhiti Morita, Dalísio de Santi Neto, Flávio Hiroshi Ananias Morita, Nina Kimie Morita, Suzana Margareth Lobo · 2015 · Obesity Surgery
  97. Treatment of Atherogenic Liver Based on the Pathogenesis of Nonalcoholic Fatty Liver Disease: A Novel Approach to Reduce Cardiovascular Risk?
    Mauro Maurantonio, Stefano Ballestri, Maria Rosaria Odoardi, Amedeo Lonardo, Paola Loria · 2011 · Archives of Medical Research
  98. Antifibrotic Therapies: Will We Ever Get There?
    Alexander J. V. Thompson, Keyur Patel · 2010 · Current Gastroenterology Reports
  99. Pharmacological and non-pharmacological treatment of non-alcoholic fatty liver disease
    Susanne Kaser, Christoph F. Ebenbichler, Herbert Tilg · 2010 · International Journal of Clinical Practice
  100. Clinical Review of Nonalcoholic Steatohepatitis in Liver Surgery and Transplantation
    Amit D. Tevar, Calissia Clarke, Jiang Wang, Steven M. Rudich, E. Steve Woodle, Alex B. Lentsch, M. L. EDWARDS · 2010 · Journal of the American College of Surgeons